Member Info for jam2morrow

I think we will see 80p-90p pre decision. Its tricky, touched 110p last time and surely must be more chance of positive outcome this time ? Against this we have much more restrained wider market.
What is this worth with FDA green light .....has to be 110p plus. Thats doubling ur money with what ?.....10% chance of failure ? Still a very good bet at these levels.
DYOR ....and never take advice from chat boards :0)

I have posted this before:
A quick internet trawl came up with this one:
Novartis receives CRL for Leqvio(inclisiran) 11/12/2020
re-submission 6/7/2021
FDA approval 22/12/2021
So slightly before 6mths was up. Sometimes FDA will announce before the final day......is it Sep 30 here ?
DYOR etc etc
Well done to everybody brave enough, and confident enough, to get some at sub 40p

they bought, not insignificant amounts at 53p and 47p after the reject decision. Is there anything to stop them buying now? or do they have to wait until FDA makes next decision ?

bought a few more....surely can't go much lower !! ......he says, for the umpteenth time

good article@agricore with insight into how tin markets work. Our sp will be v reliant on tin prices until the lithium and tantalum gets nearer to production. Should have taken some profit in the 9's but its easy in hindsight. Happy to hold

tin future prices $35k per tonne is 30% down on year highs. Energy prices rising, shipping prices rising. Remember, this tin is smelted in (is it Thailand?). If a recession is coming then people are not going to be buying as many big electronic goods and tin solder less in demand.
All that said, I think this company is a good investment; one of the best AIM miners. People, and markets are nervous, if more small economy countries default on debt, then they will become more nervous

I would like to think there will be some form of closure in this tax year. It has been previously posted that these shares can be classed as negligable value for tax purposes.......but I didn't have taxable disposals last year to be able to confirm this

Depends on the price action @Sammy. If it rises sharply then I would take some out, if it doesn't, decision becomes more complicated. Remember what we ''supposedly'' had last time - 90% it gets approval. So do you think that £1.10 represents 90% of an FDA approved POLX.......or do you think the smart money felt that POLX was only, say, 75% likely to be approved and that £1,10 represented that probability ? Hmmmm

yes, no surprises, cash burn manageable, sp should rise thru summer. Any buyers waiting on the sidelines should be satisfied and look to get back in, should bump up today

there's one(or two) at @15.00 - 100k shares sold. Results tomorrow, I don't think any surprises and bought a few more this morning........but i've been wrong before

if a manufacturing process needs to be assessed then its an automatic class2/6mths . My inference is that this was the issue.
The cash burn we'll get an understanding of next week. I am surprised this has gone so low because of the spike to 65p on the re-submission. Maybe a lot of buyers didn't research and were expecting class 1 ?

seem to be the reason why we're taking a beating. Chinese covid situation does seem a bit weird compared to everywhere else. I didn't think we'd be back in the 6ps so I won't call the bottom, but drop does feel overdone.

did CEO say profit above $80/t ? I expect that's gone up a bit with fuel, shipping costs. $150 sounds good tho ?

A quick internet trawl came up with this one:
Novartis receives CRL for Leqvio(inclisiran) 11/12/2020
re-submission 6/7/2021
FDA approval 22/12/2021
I take it this was a class 2 as well because there were issues with a production facility. Anyway, here we have slightly less than 6mths. I'm sure there are other examples to be found. If its a fixed date then it makes trading strategies easy to plan, however, it looks like an announcement could come slightly earlier

class 1 resubmissions decision within 2 months
class 2 resubmissions within 6 months
ours is a class 2, and my GUESS is that this is because a manufacturing proceedure needs to be assessed.
Sept 30th is the full 6 months. Are resubmissions sometimes decided upon well within the time frame? I cant find anything at the moment, but there must be some info on the web, or posters here with industry knowledge ?

Topped up again at this price. We have a date now and that will focus minds and budgets. The price action in the run-up to last Octobers date is there for all to see, and if we have similar this time, then this would appear to be easy money. Slim(very IMO) outside chance of a raise ? that could trip me up. Might get slightly cheaper than 54 but will definitely be higher in the run-up to announcement; then either de-risk or stay in for the decision. DYOR , no guarantees,etc, etc

If its GF selling down then they would have to notify at every percentage increment....I think ? and there has been no notification. The solar world creditors received shares that were locked in for specified time periods, the last of which was at the end of 2021.
My take is that the market is worried about the cost of power supply, particlarly gas, for German industry. Znwd may well be considering changes to the proposed industrial processes because of power issues (I assume that roasting kilns were designed using gas firing). There is an argument that the rising price of Lithium products compensates for power supply/cost issues, but I do not subscibe fully to this argument.
China will have cheap(er) power for industry but it depends how green/local, European car manufacturers want their EV batteries to be

@wetdream - thnx for that. Waites and Alexandres approach to the risk sounds like it will be different from mine. I do agree with them that the cash positiion looks ok and so don't anticipate any dilution before decision. If we get an exact date Sep/Oct that will help me. Tactical play from here for me

Hopefully the petalite question will be covered in the presentation. The original plan was to produce a 'technical grade' lithium to be used in the ceramics industry; i think its addition means that firing can be performed using less heat ?? Lately the co' has mentioned battery grade lithium so maybe they've had a re-think. It has been RNSed that spodumene was discovered on some licences. Chemicaly, they are similar LiAlSi(4)O(10) and LiAlSi(2)O(6) so I wonder if the same treatment would recover Li product from both sources? Battery grade is all about purity.
All these EV's are going to be using a lot of solder. The Tin is the main reason I'm here.

@xxxA My underderstanding of the re-submission process is this:
FDA will look at the re-submission and designate it a class1 or class2 status, or if they do not feel it addresses CRL concerns they will return it. Polx will be notified of this decision within 30 days,
Class 1 re-submissions will take 2 months to decide......Class 2 will take 6 months....I do not know if precise dates are set here, somebody else may.
A re-submission that involves looking at new manufacturing/production methods will be class 2 (my understanding only). DYOR etc but I think end of Sep or Oct before we know